HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical characteristics and prognostic factors of distant metastatic penile cancer].

AbstractOBJECTIVE:
To investigate the clinical features of distant metastatic penile cancer (DMPC) and the factors influencing its prognosis.
METHODS:
We searched the Surveillance, Epidemiology and End Results Database for cases of DMPC diagnosed between 2004 and 2019, analyzed their clinical characteristics and the cancer-specific survival (CSS) rates relating to different factors using the Kaplan-Meier method and the differences among the variables by log-rank test. We determined the variables independently associated with CSS by Cox regression analysis.
RESULTS:
According to the inclusion criteria, 108 cases of DMPC were identified. The patients were mainly married White people, with a median CSS of 9 months, and 1-, 2- and 3-year CSS rates of 36.4%, 17.8% and 13.5%, respectively. Pairwise comparison showed no statistically significant differences in the median overall CSS among the patients in the surgery, chemotherapy and surgery + chemotherapy groups (8 mo vs 9 mo vs 13 mo, P > 0.05). Race was an independent factor affecting the prognosis of CSS.
CONCLUSION:
Distant metastatic penile cancer is a rare malignancy with poor prognosis, for which there have been no existing ideal treatment options.
AuthorsChao-Peng Tang, Kai Zhou, Zheng-Cheng Sheng, Yu-Lin Zhou, Shui-Gen Zhou, Song Xu
JournalZhonghua nan ke xue = National journal of andrology (Zhonghua Nan Ke Xue) Vol. 29 Issue 2 Pg. 151-157 (Feb 2023) ISSN: 1009-3591 [Print] China
PMID37847087 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Dimyristoylphosphatidylcholine
Topics
  • Male
  • Humans
  • Prognosis
  • Neoplasm Staging
  • Penile Neoplasms (therapy)
  • Dimyristoylphosphatidylcholine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: